Is my portfolio
One Report to Answer all your Questions!
Glenmark Pharmaceuticals informs about press release
Date: 24-02-2016Glenmark Pharmaceuticals has informed about a press release dated February 24, 2016, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg’.
The above information is a part of company’s filings submitted to BSE.